Development Level

Tbio 6 | 11,445
Tclin 4 | 613
Tchem 3 | 1,598
Tdark 1 | 6,588

IMPC Phenotype

increased circulating HDL chol... 1 | 80
increased circulating creatini... 1 | 38

Disease

Carcinoma 11 | 11,493
osteosarcoma 7 | 7,950
Gout 5 | 106
nephrosclerosis 5 | 333
psoriasis 5 | 6,694
Chronic gouty arthritis 4 | 4
Hyperuricemia 4 | 49
Systemic primary carnitine deficiency disease 4 | 15
adult high grade glioma 4 | 3,801
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,989
ovarian cancer 4 | 8,520
Adjunct Treatment to Inhibit Renal Drug Excretion 3 | 3
Articular gout 3 | 11
Coxsackievirus Infections 3 | 6
Gingivitis 3 | 29
Kidney disease 3 | 430
Mouth Infection Prevention 3 | 5
Myocarditis 3 | 18
Obesity 3 | 678
colon cancer 3 | 1,478
ependymoma 3 | 4,679
group 3 medulloblastoma 3 | 4,104
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
lung cancer 3 | 4,740
lung carcinoma 3 | 2,843
malignant mesothelioma 3 | 3,232
medulloblastoma, large-cell 3 | 6,241
pancreatic cancer 3 | 2,398
tuberculosis 3 | 2,010
Acquired metabolic disease 2 | 336
Arthritis, Rheumatoid 2 | 174
Astrocytoma, Pilocytic 2 | 3,081
Ataxic cerebral palsy 2 | 7
Atherosclerosis 2 | 291
Autosomal recessive predisposition 2 | 1,442
Chromosome 3q29 microdeletion syndrome 2 | 11
Crohn's disease 2 | 321
Inflammatory bowel disease 5 2 | 14
Prostate cancer 2 | 175
Prostatic Neoplasms 2 | 495
Rheumatoid arthritis 2 | 1,191
acute quadriplegic myopathy 2 | 1,158
glioblastoma 2 | 5,792
interstitial cystitis 2 | 2,312
invasive ductal carcinoma 2 | 2,951
lung adenocarcinoma 2 | 2,716
nasopharyngeal carcinoma 2 | 1,058
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
ulcerative colitis 2 | 1,819
Acquired immunodeficiency syndrome 1 | 197
Acute kidney injury 1 | 70
Acute monocytic leukemia 1 | 13
Bipolar I disorder 1 | 23
Bleeding time prolonged 1 | 31
Breast Neoplasms 1 | 445
COPD 1 | 118
Calcinosis 1 | 70
Cardiac arrest 1 | 36
Cardiomegaly 1 | 116
Chemical and Drug Induced Liver Injury 1 | 195
Cleidocranial dysplasia 1 | 10
Colorectal Neoplasms 1 | 243
Comatose 1 | 56
Confusion 1 | 21
Decreased platelet count 1 | 111
Ecchymosis 1 | 66
Epistaxis 1 | 43
Fatigue 1 | 182
Fatty Liver 1 | 70
Hematologic cancer 1 | 12
Hepatitis C 1 | 94
Hyperammonemia 1 | 30
Hypoplastic myelodysplasia 1 | 18
Impaired platelet aggregation 1 | 8
Increased number of platelets 1 | 14
Increased tendency to bruise 1 | 66
Inflammatory Bowel Diseases 1 | 35
Juvenile Myelomonocytic Leukemia 1 | 21
Kidney Diseases 1 | 114
Lethargy 1 | 77
Leukemia, Myelocytic, Acute 1 | 120
Leukemia, Myeloid, Acute 1 | 105
Leukemia, Myelomonocytic, Juvenile 1 | 20
Lymphoma 1 | 81
MYELODYSPLASTIC SYNDROME 1 | 53
Mammary Neoplasms 1 | 425
Medium chain acyl-CoA dehydrogenase deficiency 1 | 13
Muscle Weakness 1 | 170
Myelodysplastic Syndromes 1 | 26
Myeloproliferative disease 1 | 16
Myocardial Infarction 1 | 151
Recurrent hypoglycemia 1 | 4
Respiratory Failure 1 | 104
Thrombocytopenia 1 | 197
Thrombocytosis 1 | 38
Tracheomalacia 1 | 22
chronic kidney disease 1 | 90
inflammatory breast cancer 1 | 286
uncontrolled asthma 1 | 56

Tissue

Urinary Tract 14 | 16,678
Digestive Tract 13 | 17,369
Nervous System 12 | 16,725
Blood and immune system 11 | 16,909
Endocrine System 11 | 18,159
Liver and Pancreas 11 | 16,750
Skin and soft tissues 11 | 17,230
Female tissues 10 | 17,400
Male tissues 10 | 17,142
Cardiovascular System 8 | 15,192
Respiratory system 8 | 16,393

Target Family

Transporter 13 | 473
Transcription Factor 1 | 1,400

Reactome Pathway

Organic cation/anion/zwitterio... 14 | 14
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Solute carrier family 22 member 7 SLC22A7 Tbio Transporter -2.14673 131.0 76
Solute carrier family 22 member 3 SLC22A3 Tchem Transporter -2.08897 125.3 156
Solute carrier family 22 member 18 SLC22A18 Tbio Transporter -2.37972 229.8 107
Solute carrier family 22 member 4 SLC22A4 Tbio Transporter -3.09928 1238.9 82
Solute carrier family 22 member 1 SLC22A1 Tchem Transporter -2.16768 152.4 206
Solute carrier family 22 member 11 SLC22A11 Tclin Transporter -1.72411 53.2 59
Solute carrier family 22 member 8 SLC22A8 Tclin Transporter -2.40126 258.4 113
Solute carrier family 22 member 12 SLC22A12 Tclin Transporter -2.49460 306.7 99
Solute carrier family 22 member 5 SLC22A5 Tbio Transporter -2.47467 297.1 113
Solute carrier family 22 member 16 SLC22A16 Tbio Transporter -1.42855 25.4 105